IQVIA Stocks Rises on 2Q Gains, Ballooning Backlog

Dow Jones

Jul 28

Shares of IQVIA Holdings were higher after the company cleared earnings and revenue projections for the second quarter and delivered a major jump in backlog and bookings.

The stock was up 8.3% at $230.99 in premarket trading. Shares had been slowly recovering from a major tumble in February and are now $15 away from a 52-week high.

The company, a major research organization and top provider of biopharmaceutical development and commercial outsourcing services, said revenue climbed 8.7% to $4.37 billion, topping estimates for $4.3 billion from analysts polled by FactSet.

IQVIA posted adjusted earnings of $3.15 a share, beating analyst forecasts for $3.03 a share.

Net new bookings were up 19% from the year prior and the company ended the quarter with a backlog of $34.2 billion, with expectations to convert about $9.2 billion of that into revenue in the next year.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2654004563"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2654004563\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2654004563?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 20:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654004563","market":"hk","top_or_hot":-1,"title":"IQVIA Stocks Rises on 2Q Gains, Ballooning Backlog","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of IQVIA Holdings were higher after the company cleared earnings and revenue projections for the second quarter and delivered a major jump in backlog and bookings. \n</p>\n<p>\n  The stock was up 8.3% at $230.99 in premarket trading. Shares had been slowly recovering from a major tumble in February and are now $15 away from a 52-week high. \n</p>\n<p>\n  The company, a major research organization and top provider of biopharmaceutical development and commercial outsourcing services, said revenue climbed 8.7% to $4.37 billion, topping estimates for $4.3 billion from analysts polled by FactSet. \n</p>\n<p>\n  IQVIA posted adjusted earnings of $3.15 a share, beating analyst forecasts for $3.03 a share. \n</p>\n<p>\n  Net new bookings were up 19% from the year prior and the company ended the quarter with a backlog of $34.2 billion, with expectations to convert about $9.2 billion of that into revenue in the next year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IQVIA Stocks Rises on 2Q Gains, Ballooning Backlog</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIQVIA Stocks Rises on 2Q Gains, Ballooning Backlog\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-28 20:08</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of IQVIA Holdings were higher after the company cleared earnings and revenue projections for the second quarter and delivered a major jump in backlog and bookings. \n</p>\n<p>\n  The stock was up 8.3% at $230.99 in premarket trading. Shares had been slowly recovering from a major tumble in February and are now $15 away from a 52-week high. \n</p>\n<p>\n  The company, a major research organization and top provider of biopharmaceutical development and commercial outsourcing services, said revenue climbed 8.7% to $4.37 billion, topping estimates for $4.3 billion from analysts polled by FactSet. \n</p>\n<p>\n  IQVIA posted adjusted earnings of $3.15 a share, beating analyst forecasts for $3.03 a share. \n</p>\n<p>\n  Net new bookings were up 19% from the year prior and the company ended the quarter with a backlog of $34.2 billion, with expectations to convert about $9.2 billion of that into revenue in the next year. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2654004563","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2654004563","pubTimestamp":1785240480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of IQVIA Holdings were higher after the company cleared earnings and revenue projections for the second quarter and delivered a major jump in backlog and bookings.The stock was up 8.3% at $230.99 in premarket trading. Shares had been slowly recovering from a major tumble in February and are now $15 away from a 52-week high.The company, a major research organization and top provider of biopharmaceutical development and commercial outsourcing services, said revenue climbed 8.7% to $4.37 billion, topping estimates for $4.3 billion from analysts polled by FactSet.IQVIA posted adjusted earnings of $3.15 a share, beating analyst forecasts for $3.03 a share.Net new bookings were up 19% from the year prior and the company ended the quarter with a backlog of $34.2 billion, with expectations to convert about $9.2 billion of that into revenue in the next year.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","BK4121":"生命科学工具和服务","IQV":"艾昆纬","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","EKG":"First Trust Nasdaq Lux Digital Health Solutions ETF","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","BK4530":"医药外包概念","HEAL":"Global X HealthTech ETF","BK4588":"碎股","LU0882574055.USD":"富达全球健康医疗A ACC","LU1261432733.SGD":"Fidelity World A-ACC-SGD"},"translate_title":"IQVIA 股价因第二季度上涨和积压订单不断增加而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EKG":0.6,"HEAL":0.6,"IQV":1.5},"content_text":"Shares of IQVIA Holdings were higher after the company cleared earnings and revenue projections for the second quarter and delivered a major jump in backlog and bookings. \n\n\n  The stock was up 8.3% at $230.99 in premarket trading. Shares had been slowly recovering from a major tumble in February and are now $15 away from a 52-week high. \n\n\n  The company, a major research organization and top provider of biopharmaceutical development and commercial outsourcing services, said revenue climbed 8.7% to $4.37 billion, topping estimates for $4.3 billion from analysts polled by FactSet. \n\n\n  IQVIA posted adjusted earnings of $3.15 a share, beating analyst forecasts for $3.03 a share. \n\n\n  Net new bookings were up 19% from the year prior and the company ended the quarter with a backlog of $34.2 billion, with expectations to convert about $9.2 billion of that into revenue in the next year.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}